Director, Value, Evidence & Outcomes Liaison (VEOL) – Central
ArcellxFull Time
Mid-level (3 to 4 years)
Key technologies and capabilities for this role
Common questions about this position
Candidates need a Master or PhD in Health Policy, Pharmaco-economics, Public Health, Epidemiology, Pharmacy administration, data science or related fields, plus 7+ years of experience in HEOR/RWE in consulting, pharma, or academia. Strong analytical skills with proficiency in R and SAS, a track record of publications in English peer-reviewed journals, and excellent English writing abilities are also required.
Responsibilities include developing research in Health Economics, Outcomes Research & Real-World Evidence such as economic modeling and observational studies, creating value-evidence strategies and dossiers, designing studies, project management, client liaison, and delivering strategic advice on pricing, reimbursement, and market access.
The position is full-time.
The HTA/HE team is young, energetic, and fast-growing, consisting of master and PhD level researchers/consultants with strong academic backgrounds, collaborating globally to explore new methodologies and deliver high-quality solutions.
Strong candidates will have advanced degrees in relevant fields, 7+ years in HEOR/RWE, proficiency in R and SAS, publications in peer-reviewed journals, and excellent English writing skills, demonstrating the ability to handle complex research and client management.
Advanced analytics and clinical research services
IQVIA provides advanced analytics, technology solutions, and clinical research services specifically for the life sciences industry. Their services utilize extensive data resources and technology to create connections within healthcare, allowing clients to gain insights that help speed up the development and marketing of new medical treatments. This process is facilitated by their IQVIA Connected Intelligence™ system, which offers quick and flexible insights. IQVIA stands out from competitors by focusing on patient privacy, employing various technologies to protect individual data. The company's goal is to enhance healthcare outcomes by supporting biotech, pharmaceutical, and medical device companies, as well as researchers and government agencies, in understanding diseases and advancing medical science.